Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jul 27, 2025; 17(7): 106487
Published online Jul 27, 2025. doi: 10.4240/wjgs.v17.i7.106487
Published online Jul 27, 2025. doi: 10.4240/wjgs.v17.i7.106487
Table 5 Cox proportional hazards model
Model 1 | Model 2 | Model 3 | ||||
HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | |
Ineffective group | Ref | Ref | Ref | |||
Effective group | 0.624 (0.437-0.986) | 0.019 | 0.727 (0.421-0.833) | 0.008 | 1.439 (1.208-1.614) | 0.006 |
CD3+ | 0.422 (0.309-0.528) | 0.026 | 0.608 (0.417-0.839) | 0.000 | 0.619 (0.455-0.808) | 0.000 |
CD4+ | 0.122 (0.019-0.321) | 0.021 | 0.218 (0.107-0.474) | 0.044 | 0.344 (0.274-0.541) | 0.042 |
CA199 | 1.242 (1.024-1.842) | 0.005 | 1.789 (1.424-1.872) | 0.028 | 1.678 (1.564-1.971) | 0.004 |
IL-6 | 1.341 (1.276-1.452) | 0.038 | 1.541 (1.442-1.772) | 0.001 | 1.841 (1.652-1.938) | 0.000 |
- Citation: Ma HY, Liu X, Chen YW, Liang J, Wang J, Zhang MM, Yang Q. Baohe Pingwei power plus neoadjuvant chemotherapy for gastric cancer. World J Gastrointest Surg 2025; 17(7): 106487
- URL: https://www.wjgnet.com/1948-9366/full/v17/i7/106487.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i7.106487